Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array-based solutions for genetic and genomic analysis. The one-month return of Illumina, Inc. (NASDAQ:ILMN) was -32.97%, and its shares lost 34 ...

Despite these advancements, companies like Illumina face challenges due to policy changes and ... In January 2024, Thermo Fisher Scientific introduced the Axiom PangenomiX Array, a human genomics ...

Moreover, array-based CGH (aCGH) has become increasingly popular ... The major market players like Illumina, Thermo Fisher Scientific, and Agilent Technologies operate in the region and also ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

Founded in 1998, Illumina is a genetic testing company. It develops DNA sequencing and array-based life sciences technologies to enable research discovery. Illumina sells a number of DNA sequencing ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

For the first time, China has put American genome-sequencing equipment manufacturer Illumina on its “unreliable entity list”. The move was a direct counter to the US imposing sanctions on Beijing ...

Syngenta Group was the largest competitor with a 3.47% share of the market, followed by Amgen Inc with 3.29%, Monsanto (Bayer) AG with 1.48%, Illumina Inc with 1.20%, F. Hoffmann-La Roche Ltd ...

Syngenta Group was the largest competitor with a 3.47% share of the market, followed by Amgen Inc with 3.29%, Monsanto (Bayer) AG with 1.48%, Illumina Inc with 1.20%, F. Hoffmann-La Roche Ltd ...

Syngenta Group was the largest competitor with a 3.47% share of the market, followed by Amgen Inc with 3.29%, Monsanto (Bayer) AG with 1.48%, Illumina Inc with 1.20%, F. Hoffmann-La Roche Ltd.

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

Agilent’s Microarray Hybridization Oven was designed for optimal hybridization performance and ultimately, consistently reliable data. With advanced features including variable and adjustable ...